Programming Immunity Against Pancreatic Cancer: Neoantigens, mRNA Vaccines, and the Limits of an Immunologically Cold Tumor
Pancreatic ductal adenocarcinoma (PDAC) occupies a uniquely hostile position in the oncological landscape,…
Browsing Category
2 articles
Recent Advances in TB Regimen: Is It an Optimization in a Limited Subset of Patients or Supports Global Application?
Abstract Recent clinical trials have introduced shortened antituberculosis regimens for both drug-susceptible…
